Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danaparoid dosing during continuous venovenous hemofiltration pilot study
NL-OMON30497Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of danaparoid sodium and heparin in acute kidney failure (AKF) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Area under the curve of serial anti-Xa measurements, Circuit survival time and 1 more. Planned start Oct 2007; status: not yet recruiting.
02
Drugs
danaparoid sodiumheparin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NL-OMON30497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30497.